Loading live market data…

AnaptysBio, Inc.

NASDAQ:ANAB

$62.51 USD

-$7.3 (-10.46%)

Volume
623.07K
Average Volume
674.8K
Market Capitalization
$2.7B
P/E Ratio
-73.54
Dividend Yield
0.00%
Price Target
$75.50
Year High
$72.36
Year Low
$11.40
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$7.58

ANAB Estimated and Actual Revenue by Quarter

ANAB Estimated and Actual EPS by Quarter

ANAB Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 3 -100.74M -66.62M -83.68M -101.96M -67.43M -84.69M
2027-09-30 2 -64.89M -42.92M -53.91M -65.68M -43.44M -54.56M
2027-06-30 2 -4.38M -2.9M -3.64M -4.44M -2.93M -3.68M
2027-03-31 3 -15.54M -10.28M -12.91M -15.73M -10.4M -13.07M
2026-12-31 3 -33.24M -21.99M -27.62M -33.65M -22.25M -27.95M
2026-09-30 4 -22.69M -15.01M -18.85M -22.97M -15.19M -19.08M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 3 26.71M 45.96M 36.34M 130.55M 197.39M 163.97M
2027-09-30 2 6.75M 11.61M 9.18M 84.1M 127.16M 105.63M
2027-06-30 2 1.48M 2.54M 2.01M 5.68M 8.59M 7.13M
2027-03-31 3 -2.18M -1.27M -1.72M 20.14M 30.46M 25.3M
2026-12-31 3 -347.22K -201.76K -274.49K 43.08M 65.14M 54.11M
2026-09-30 4 -4.25M 32.96M 5.85M 29.41M 44.47M 36.94M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 3 92.88M 140.43M 116.66M 1 0.9309 1.60206 1.26648
2027-09-30 2 59.83M 90.47M 75.15M 1 0.23517 0.40473 0.31995
2027-06-30 2 4.04M 6.11M 5.08M 1 0.0514519 0.0885481 0.07
2027-03-31 3 14.33M 21.67M 18M 1 -0.07589837 -0.04410163 -0.06
2026-12-31 3 30.65M 46.34M 38.5M 1 -0.012102 -0.007032 -0.009567
2026-09-30 4 20.92M 31.64M 26.28M 5 -0.14824 1.14886 0.20383